A citation-based method for searching scientific literature

Alex Mas Monteys, Shauna A Ebanks, Megan S Keiser, Beverly L Davidson. Mol Ther 2017
Times Cited: 136



Lei S Qi, Matthew H Larson, Luke A Gilbert, Jennifer A Doudna, Jonathan S Weissman, Adam P Arkin, Wendell A Lim. Cell 2013
Times Cited: 2258




List of shared articles



Times cited

Approach for in vivo delivery of CRISPR/Cas system: a recent update and future prospect.
Yu-Fan Chuang, Andrew J Phipps, Fan-Li Lin, Valerie Hecht, Alex W Hewitt, Peng-Yuan Wang, Guei-Sheung Liu. Cell Mol Life Sci 2021
4

CRISPR/Cas-Dependent and Nuclease-Free In Vivo Therapeutic Gene Editing.
Ishani Dasgupta, Terence R Flotte, Allison M Keeler. Hum Gene Ther 2021
6

In vivo genome editing in single mammalian brain neurons through CRISPR-Cas9 and cytosine base editors.
Beomjong Song, Chan Young Kang, Jun Hee Han, Masanobu Kano, Arthur Konnerth, Sangsu Bae. Comput Struct Biotechnol J 2021
0

Chromatin Alterations in Neurological Disorders and Strategies of (Epi)Genome Rescue.
Marcin Janowski, Małgorzata Milewska, Peyman Zare, Aleksandra Pękowska. Pharmaceuticals (Basel) 2021
0

A glance at genome editing with CRISPR-Cas9 technology.
Antara Barman, Bornali Deb, Supriyo Chakraborty. Curr Genet 2020
13

Allele-specific genome targeting in the development of precision medicine.
Junjiao Wu, Beisha Tang, Yu Tang. Theranostics 2020
8

CRISPR-Cas9 system: A genome-editing tool with endless possibilities.
Swati Tyagi, Robin Kumar, Aparup Das, So Youn Won, Pratyoosh Shukla. J Biotechnol 2020
9

CRISPR to the Rescue: Advances in Gene Editing for the FMR1 Gene.
Carolyn M Yrigollen, Beverly L Davidson. Brain Sci 2019
8

CRISPR/Cas: An intriguing genomic editing tool with prospects in treating neurodegenerative diseases.
Safikur Rahman, Manali Datta, Jihoe Kim, Arif Tasleem Jan. Semin Cell Dev Biol 2019
6

Programmable RNA-Guided RNA Effector Proteins Built from Human Parts.
Simone Rauch, Emily He, Michael Srienc, Huiqing Zhou, Zijie Zhang, Bryan C Dickinson. Cell 2019
37

CRISPR-engineered genome editing for the next generation neurological disease modeling.
Weijun Feng, Hai-Kun Liu, Daisuke Kawauchi. Prog Neuropsychopharmacol Biol Psychiatry 2018
6